Insulin degludec and Liraglutide

Therapeutic indications

Insulin degludec and Liraglutide is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Insulin degludec/liraglutide combination is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Insulin degludec and Liraglutide is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Diabetes mellitus type 1, diabetic ketoacidosis

at least one of
Diabetes mellitus type I
Diabetic ketoacidosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: XULTOPHY Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈